United Therapeutics Corporation UTHR
NASDAQ · United States · Health Technology
$541.89+60.42 (+12.55%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 7.27 | 6.86 | +6.0% | $783.30M | -2.7% | +2.7%$518.68→$532.94 |
| Q1 2026 | 2026-05-06 | 5.82 | 6.73 | -13.5% | — | — | -0.5% |
| Q4 2025 | 2026-02-25 | 7.70 | 6.76 | +13.9% | — | — | +6.4%$473.43→$503.60 |
| Q3 2025 | 2025-10-29 | 7.16 | 6.89 | +3.9% | — | — | +9.2%$415.34→$453.53 |
| Q4 2024 | 2025-02-26 | 6.19 | 6.27 | -1.3% | — | — | — |
| Q4 2023 | 2024-02-21 | 4.36 | 4.19 | +4.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.